Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Flexible electronics are the next generation of sensors for mobile health and implantation. Zebrafish (Danio rerio) is an emergent
strategy for pre-clinical drug development and toxicity testing. To address the confounding effects from sedation of fish and
removal from the aquatic habitat for micro-electrocardiogram (�¼ECG) measurements, we developed waterproof and wearable sensors
to uncover the circadian variation in heart rate (HR) and heart rate variability (HRV). The parylene-C based ECG sensor consisted
of an ultra-soft silicone integrated jacket designed to wrap around the fish during swimming. The Young's modulus of this silicone
jacket matched with the fish surface and an extended parylene cable connected the underwater chest electrodes with the out-of water
electronics. In addition, embedded micro-glass spheres in the silicone effectively reduced the effective density of the jacket to ~1 g
cm-3. These innovations enabled physiological ECG telemetry in the fish's natural habitat without the need for sedation. Furthermore,
a set of non-linear signal processing techniques filtered out the breathing and electromagnetic artifacts from the recorded signals.
We observed a reduction in mean HR and an increase in HRV over 24 hours at 10 dpa, accompanied by QT prolongation as well as
diurnal variations, followed by normalization in mean HR and QT intervals at 26 days post ventricular amputation (dpa). We revealed
Amiodarone-mediated QTc prolongation, HR reduction and HRV increase otherwise masked by sedation. The novel features of the
flexible silicon jacket for �¼ECG telemetry unraveled the biological clock and normalization of QT intervals at 26 dpa, providing the
first evidence of new physiological phenomena during cardiac injury and repair as well as cardiac drug-mediated aberrant rhythms.
Thus, the light weight and waterproof design holds promise to advance the next generation of mobile health and drug discovery.